``` REGISTERED CHARITY NUMBER: 1101433 ``` ``` Report of the Trustees and Financial Statements for the Year Ended 31 October 2020 for EPSOM MEDICAL RESEARCH ``` ``` Sandison Lang Limited 2 St Marys Road Tonbridge Kent TN9 2LB ``` ``` EPSOM MEDICAL RESEARCH ``` ``` Contents of the Financial Statements for the Year Ended 31 October 2020 ``` ||`Page`| |---|---| |`Report of the Trustees`|`1 to 2`| |`Independent Examiner's Report`|`3`| |`Statement of Financial Activities`|`4`| |`Balance Sheet`|`5`| |`Notes to the Financial Statements`|`6 to 9`| |`Detailed Statement of Financial Activities`|`10`| ## **`EPSOM MEDICAL RESEARCH`** ## **`Report of the Trustees`** ## **`for the Year Ended 31 October 2020`** ``` Thetrusteespresenttheirreportwiththefinancialstatementsofthecharityfortheyear ended 31October2020.ThetrusteeshaveadoptedtheprovisionsoftheStatementofRecommended Practice (SORP) 'Accounting and Reporting by Charities' issued in March 2005. ``` ## **`REFERENCE AND ADMINISTRATIVE DETAILS Registered Charity number`** ``` 1101433 ``` ## **`Principal address`** ``` 85 Rydens Road Elmbridge Walton-on-Thames Surrey KT12 3AN ``` ## **`Trustees`** ``` Dr. L G Darlington Ms S Kumar K W D Ramsey ``` ## **`Independent examiner`** ``` Sandison Lang Limited 2 St Marys Road Tonbridge Kent TN9 2LB ``` ## **`STRUCTURE, GOVERNANCE AND MANAGEMENT`** ## **`Governing document`** ``` Thecharityiscontrolledbyitsgoverningdocument,adeedoftrust,andconstitutesan unincorporated charity. ``` ## **`Risk management`** ``` Thetrusteeshaveadutytoidentifyandreviewtheriskstowhichthecharityisexposedandto ensure appropriate controls are in place to provide reasonable assurance against fraud and error. ``` ## **`OBJECTIVES AND ACTIVITIES`** ## **`Objectives and aims`** ``` TheobjectivesoftheEpsomMedicalResearchareinthefieldofresearchwithintheareas of rheumatology, general medicine, inflammation, neuroscience and cancer. ``` ## **`ACHIEVEMENT AND PERFORMANCE`** ## **`Charitable activities in the year`** ``` The Charity supported research into the areas defined in its objectives during the year. ``` ``` Page 1 ``` ## **`EPSOM MEDICAL RESEARCH`** ## **`Report of the Trustees`** ## **`for the Year Ended 31 October 2020`** ``` Approved by order of the board of trustees on 26 August 2021 and signed on its behalf by: ``` ``` Dr. L G Darlington - Trustee ``` ``` Page 2 ``` ``` Independent Examiner's Report to the Trustees of Epsom Medical Research ``` ``` I report on the accounts for the year ended 31 October 2020, which are set out on pages four to nine. ``` ## **`Responsibilities and basis of report`** ``` Asthecharity'strusteesyouareresponsibleforthepreparationoftheaccountsinaccordancewith the requirements of the Charities Act 2011 ('the Act'). ``` ``` I haveexaminedyourcharity'saccountsas requiredunder section145of the CharitiesAct 2011('the Act'). IncarryingoutmyexaminationIhavefollowedtheDirectionsgivenbytheCharityCommission under section 145(5)(b) of the 2011 Act. ``` ``` My role is to state whether any material matters have come to my attention giving me cause to believe: ``` `1. that accounting records were not kept as required by section 130 of the Act; or` `2. that the accounts do not accord with those records; or` `3. that the accounts do not comply with the accounting requirements of the Act; or` `4. that there is further information needed for a proper understanding of the accounts.` ## **`Independent examiner's statement`** ``` Ihavecompletedmyexaminationandhavenoconcernsinrespectofthematters(1)to(4)listed above and,inconnectionwithfollowingtheDirectionsoftheCharityCommissionIhavefoundnomatters that require drawing to your attention. ``` ``` Mr Ryan Cottington FCCA Sandison Lang Limited 2 St Marys Road Tonbridge Kent TN9 2LB ``` ``` 26 August 2021 ``` ``` Page 3 ``` ## **`EPSOM MEDICAL RESEARCH`** ## **`Statement of Financial Activities`** ## **`for the Year Ended 31 October 2020`** |**`2020`**
**`Unrestricted`**
**`fund`**
`Notes`
**`£`**
**`INCOMING RESOURCES`**
**`Incoming resources from generated funds`**
`Voluntary income`
**`45,395`**
`Investment income`
`2`
**`-`**
**`Total incoming resources`**
**`45,395`**
**`RESOURCES EXPENDED`**
**`Charitable activities`**
`Grants`
**`62,465`**
**`Other resources expended`**
**`1,682`**
**`Total resources expended`**
**`64,147`**
**`NET INCOMING/(OUTGOING) RESOURCES`**
**`(18,752)`**
**`RECONCILIATION OF FUNDS`**
**`Total funds brought forward`**
**`(194,786)`**
**`TOTAL FUNDS CARRIED FORWARD`**
**`(213,538)`**|`2019`
`Total`
`funds`
`£`
`41,035`
`57`
`41,092`
`35,770`
`1,658`
`37,428`
`3,664`
`(198,450)`
`(194,786)`| |---|---| ``` The notes form part of these financial statements ``` ``` Page 4 ``` ## **`EPSOM MEDICAL RESEARCH`** ## **`Balance Sheet`** ## **`At 31 October 2020`** |**`2020`**
**`Unrestricted`**
**`fund`**
`Notes`
**`£`**
**`CURRENT ASSETS`**
`Debtors`
`4`
**`9,288`**
`Cash at bank`
**`10,382`**
**`19,670`**
**`CREDITORS`**
`Amounts falling due within one year`
`5`
**`(233,208)`**
**`NET CURRENT ASSETS/(LIABILITIES)`**
**`(213,538)`**
**`TOTAL ASSETS LESS CURRENT LIABILITIES`**
**`(213,538)`**
**`NET ASSETS/(LIABILITIES)`**
**`(213,538)`**
**`FUNDS`**
`6`
`Unrestricted funds`
**`(213,538)`**
**`TOTAL FUNDS`**
**`(213,538)`**|`2019`
`Total`
`funds`
`£`
`209`
`24,658`
`24,867`
`(219,653)`
`(194,786)`
`(194,786)`
`(194,786)`
`(194,786)`
`(194,786)`| |---|---| ``` ThefinancialstatementswereapprovedbytheBoardofTrusteeson26August2021andweresigned on its behalf by: ``` ``` Dr. L G Darlington -Trustee ``` ``` The notes form part of these financial statements ``` ``` Page 5 ``` ``` EPSOM MEDICAL RESEARCH ``` ``` Notes to the Financial Statements for the Year Ended 31 October 2020 ``` ## **`1. ACCOUNTING POLICIES`** ## **`Accounting convention`** ``` Thefinancialstatementshavebeenpreparedunderthehistoricalcostconvention,and in accordancewiththeFinancialReportingStandardforSmallerEntities(effectiveApril2008), the CharitiesAct2011andtherequirementsoftheStatementofRecommendedPractice, Accounting and Reporting by Charities. ``` ## **`Incoming resources`** ``` AllincomingresourcesareincludedontheStatementofFinancialActivitieswhenthecharity is legally entitled to the income and the amount can be quantified with reasonable accuracy. ``` ## **`Resources expended`** ``` Expenditureisaccountedforonanaccrualsbasisandhasbeenclassifiedunderheadings that aggregateallcostrelatedtothecategory.Wherecostscannotbedirectlyattributedto particular headings they have been allocated to activities on a basis consistent with the use of resources. ``` ``` Grantsofferedsubjecttoconditionswhichhavenotbeenmetattheyearenddatearenotedas a commitment but not accrued as expenditure. ``` ## **`Taxation`** ``` The charity is exempt from tax on its charitable activities. ``` ## **`Fund accounting`** ``` Unrestrictedfundscanbe usedin accordancewiththecharitableobjectivesat thediscretionof the trustees. ``` ``` Restrictedfunds can only be used for particularrestrictedpurposeswithin the objectsof the charity. Restrictionsarisewhenspecifiedbythedonororwhenfundsareraisedforparticular restricted purposes. ``` ``` Furtherexplanationofthenatureandpurposeofeachfundis includedin thenotestothe financial statements. ``` ## **`2. INVESTMENT INCOME`** ||**`2020`**|`2019`| |---|---|---| ||**`£`**|`£`| |`Deposit account interest`|**`-`**|`57`| ``` Page 6 ``` ``` EPSOM MEDICAL RESEARCH ``` ``` Notes to the Financial Statements - continued for the Year Ended 31 October 2020 ``` ## **`3. TRUSTEES' REMUNERATION AND BENEFITS`** ``` Therewere no trustees'remunerationor otherbenefitsfor the yearended 31 October2020nor for the year ended 31 October 2019. ``` ## **`Trustees' expenses`** ``` Therewerenotrustees'expensespaidfortheyearended31October2020norfortheyear ended 31 October 2019 . ``` ## **`4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR`** ||||**`2020`**|`2019`| |---|---|---|---|---| ||||**`£`**|`£`| ||`Other debtors`||**`9,288`**|`209`| |**`5.`**|**`CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR`**|||| ||||**`2020`**|`2019`| ||||**`£`**|`£`| ||`Other creditors`||**`208,610`**|`208,610`| ||`Accruals and deferred income`||**`24,598`**|`11,043`| ||||**`233,208`**|`219,653`| |**`6.`**|**`MOVEMENT IN FUNDS`**|||| ||||**`Net`**|| ||||**`movement`**|| |||**`At 1/11/19`**|**`in funds`**|**`At 31/10/20`**| |||**`£`**|**`£`**|**`£`**| ||**`Unrestricted funds`**|||| ||`General fund`|**`(194,786)`**|**`(18,752)`**|**`(213,538)`**| ||**`TOTAL FUNDS`**|**`(194,786)`**|**`(18,752)`**|**`(213,538)`**| ``` Page 7 ``` ``` EPSOM MEDICAL RESEARCH ``` ## **`Notes to the Financial Statements - continued for the Year Ended 31 October 2020`** ## **`6. MOVEMENT IN FUNDS - continued`** ``` Net movement in funds, included in the above are as follows: ``` ||**`Incoming`**|**`Incoming`**|**`Resources`**|**`Movement`**|| |---|---|---|---|---|---| ||**`resources`**||**`expended`**|**`in funds`**|| |||**`£`**|**`£`**|**`£`**|| |**`Unrestricted funds`**|||||| |`General fund`||**`45,395`**|**`(64,147)`**|**`(18,752)`**|| |**`TOTAL FUNDS`**||**`45,395`**|**`(64,147)`**|**`(18,752)`**|| |**`Comparatives for movement in funds`**|||||| ||||**`Net`**||| ||||**`movement`**||| ||**`At 1/11/18`**||**`in funds`**|**`At 31/10/19`**|| |||**`£`**|**`£`**|**`£`**|| |**`Unrestricted Funds`**|||||| |`General fund`|**`(198,450)`**||**`3,664`**|**`(194,786)`**|| |**`TOTAL FUNDS`**|**`(198,450)`**||**`3,664`**|**`(194,786)`**|| ||||||| ||||||| |`Comparative net movement in funds, included in the`|`above are as follows:`||||| ||**`Incoming`**||**`Resources`**|`Movement`|| ||**`resources`**||**`expended`**|`in funds`|| |||**`£`**|**`£`**|`£`|| |**`Unrestricted funds`**|||||| |`General fund`||**`41,092`**|**`(37,428)`**|**`3,664`**|| |**`TOTAL FUNDS`**||**`41,092`**|**`(37,428)`**|**`3,664`**|| ||||||| ``` Page 8 ``` ``` EPSOM MEDICAL RESEARCH ``` ## **`Notes to the Financial Statements - continued for the Year Ended 31 October 2020`** ## **`6. MOVEMENT IN FUNDS - continued`** ``` A current year 12 months and prior year 12 months combined position is as follows: ``` |||**`Net`**|| |---|---|---|---| |||**`movement`**|| ||**`At 1/11/18`**|**`in funds`**|**`At 31/10/20`**| ||**`£`**|**`£`**|**`£`**| |**`Unrestricted funds`**|||| |`General fund`|**`(198,450)`**|**`(15,088)`**|**`(213,538)`**| |**`TOTAL FUNDS`**|**`(198,450)`**|**`(15,088)`**|**`(213,538)`**| ``` Acurrentyear12monthsandprioryear12monthscombinednetmovementinfunds,included in the above are as follows: ``` ||**`Incoming`**|**`Resources`**|**`Movement`**| |---|---|---|---| ||**`resources`**|**`expended`**|**`in funds`**| ||**`£`**|**`£`**|**`£`**| |**`Unrestricted funds`**|||| |`General fund`|**`86,487`**|**`(101,575)`**|**`(15,088)`**| |**`TOTAL FUNDS`**|**`86,487`**|**`(101,575)`**|**`(15,088)`**| ``` Page 9 ``` ## **`EPSOM MEDICAL RESEARCH`** ## **`Detailed Statement of Financial Activities`** ## **`for the Year Ended 31 October 2020`** |**`INCOMING RESOURCES`**
**`Voluntary income`**
`Donations`
`Gift aid`
**`Investment income`**
`Deposit account interest`
**`Total incoming resources`**
**`RESOURCES EXPENDED`**
**`Charitable activities`**
`Research salaries`
`Research expenses`
**`Support costs`**
**`Other 4`**
`Accountancy and legal fees`
**`Total resources expended`**
**`Net (expenditure)/income`**|**`2020`**
**`£`**
**`36,316`**
**`9,079`**
**`45,395`**
**`-`**
**`45,395`**
**`34,062`**
**`28,403`**
**`62,465`**
**`1,682`**
**`64,147`**
**`(18,752)`**|`2019`
`£`
`33,141`
`7,894`| |---|---|---| |||`41,035`
`57`| |||`41,092`
`28,470`
`7,300`| |||`35,770`
`1,658`| |||`37,428`| |||`3,664`| ``` This page does not form part of the statutory financial statements ``` ``` Page 10 ```